Multi-Color Customizable Insulin GLP-1 Peptide Injection Pen for Diabetes and Weight Management

The HL100S-D series disposable pen injector represents a significant advancement in medication delivery technology for diabetes and weight management therapies. This precision-engineered device offers healthcare professionals and patients a reliable solution for administering insulin and GLP-1 peptide medications with exceptional accuracy.

Available in multiple unit configurations (36/37/50/60/74/75/80 units), this injection pen accommodates various therapeutic needs. The device features a 3mL cartridge capacity with minimum single dose capability of 0.01mL, ensuring precise medication delivery for different treatment protocols.

Key features include:

• Highly customizable appearance, color, dosage, and scale line options
• Optimized pressing force design (36/37 units <5N, 74/80 units <8N)
• Completed FTO review in China and United States with no patent risk
• Successfully applied for CDE number with CE MDR and FDA 510k submissions in progress

The pen's versatile design makes it suitable for multiple medications including liraglutide, semaglutide, insulin degludec, and follicle stimulating hormone (FSH) drugs. Its precise dosing mechanism has been validated by professional R&D teams to ensure accurate medication delivery.

With dimensions of 173mm × φ19.57mm, the pen offers comfortable handling while maintaining a professional appearance. The device has been designed for use across multiple therapeutic areas including diabetes management, osteoporosis treatment, growth hormone deficiency, Parkinson's disease, oncology, and rheumatology.

This injection pen represents a cost-effective solution for healthcare providers seeking reliable medication delivery devices that can be customized to specific patient needs and treatment protocols.